Key facts
- This page summarizes David A. Rosa's Form 4 filing for BIOTRICITY INC. (BTCY).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 15 Mar 2023, 16:22.
David A. Rosa - 12 Mar 2023 Form 4 Insider Report for BIOTRICITY INC. (BTCY)
- Reporting relationship
- Director
- Issuer ticker
- BTCY
- Reported as of
- 12 Mar 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 15 Mar 2023, 16:22:52 UTC
- Prior SEC filing
- 17 Feb 2023
- Next SEC filing
- 04 Apr 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ David Rosa
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David A. Rosa filed Form 4 for BIOTRICITY INC. (BTCY) on 15 Mar 2023.
Change
- Previous filing in this sequence was filed on 17 Feb 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BTCY
transaction
Derivative
Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +75,930
- Change %
- +19%
- Price
- $0.000000
- Shares after
- 474,683
- Date
- 12 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 75,930
- Exercise price
- $1.94
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Granted pursuant to the 2016 Equity Incentive Plan; with immediate vesting.